An Overview of Rani Therapeutics Hldgs's Earnings

Rani Therapeutics Hldgs RANI will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Rani Therapeutics Hldgs to report an earnings per share (EPS) of $-0.23.

Anticipation surrounds Rani Therapeutics Hldgs's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Overview of Past Earnings

The company's EPS beat by $0.03 in the last quarter, leading to a 3.4% drop in the share price on the following day.

Here's a look at Rani Therapeutics Hldgs's past performance and the resulting price change:

Stock Performance

Shares of Rani Therapeutics Hldgs were trading at $1.34 as of March 27. Over the last 52-week period, shares are down 56.25%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Rani Therapeutics Hldgs visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.